Okay, so let me get my bias out there right up front–health apps, mobile or otherwise, are never going to have more than a marginal impact on the health system and especially on the big issues facing the system. There are a lot of apps out there (165,000, according to the study)–how do we know useful or “good” any of them are. Many are available through Apple, Google and other heavily used consumer app stores. Consumer reviews may be available; how trustworthy are those? How about a review by experts of the most popular health apps for depression and smoking cessation in the iTunes store? That is what a study published in JMIR-mHealth provides. (App. Study) For this study, 6 experts used 22 measures to evaluate apps. The study analyzed how similar the raters evaluations were across the measures. This can be important because the closer the ratings are, the more likely you can assume they reflect the actual characteristic of the app, and the more useful the ratings are to consumers. Conversely, wide dispersion of ratings suggests that consumers would have a wide range of reactions to the app and its utility. Turns out it must be hard to come to common agreement on how good an app is on these various measures, because their was great disagreement across the raters on most measures. The greatest agreement was on matters like whether the app had password protection and gave feedback and was interactive. The least was on measures for ease of use, errors and performance problems. If experts have trouble rating apps consistently, seems unlikely consumers will be able to easily evaluate their utility.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.
Healthy Skeptic Podcast
Research
MedPAC 2019 Report to Congress
June 18, 2019
Headlines
Tags
Access
ACO
Care Management
Chronic Disease
Comparative Effectiveness
Consumer Directed Health
Consumers
Devices
Disease Management
Drugs
EHRs
Elder Care
End-of-Life Care
FDA
Financings
Genomics
Government
Health Care Costs
Health Care Quality
Health Care Reform
Health Insurance
Health Insurance Exchange
HIT
HomeCare
Hospital
Hospital Readmissions
Legislation
M&A
Malpractice
Meaningful Use
Medicaid
Medical Care
Medicare
Medicare Advantage
Mobile
Pay For Performance
Pharmaceutical
Physicians
Providers
Regulation
Repealing Reform
Telehealth
Telemedicine
Wellness and Prevention
Workplace
Related Posts
Commentary
Racist Anti-racists Are All About the Money
September 16, 2024
Racist Anti-racists Are All About the Money
Anti-racism is an industry that makes a lot of white people very rich.
Commentary
Weekly US Debt Auctions
September 16, 2024
Weekly US Debt Auctions
The ever-increasing pile of US debt makes tracking debt auction results very important.
Commentary
An Outstanding but Relatively Unknown Writer, Charles McCarry
September 14, 2024
An Outstanding but Relatively Unknown Writer, Charles McCarry
The author Charles McCarry was an outstanding writer and prescient in his understanding of what…